IRIS Accounts Production v25.4.0.155 10135975 Board of Directors 1.5.24 30.4.25 30.4.25 0 0 false true false false true false Ordinary A Shares 1.00000 Ordinary B Shares 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh101359752024-04-30101359752025-04-30101359752024-05-012025-04-30101359752023-04-30101359752023-05-012024-04-30101359752024-04-3010135975ns15:EnglandWales2024-05-012025-04-3010135975ns14:PoundSterling2024-05-012025-04-3010135975ns10:Director12024-05-012025-04-3010135975ns10:PrivateLimitedCompanyLtd2024-05-012025-04-3010135975ns10:SmallEntities2024-05-012025-04-3010135975ns10:AuditExempt-NoAccountantsReport2024-05-012025-04-3010135975ns10:SmallCompaniesRegimeForDirectorsReport2024-05-012025-04-3010135975ns10:SmallCompaniesRegimeForAccounts2024-05-012025-04-3010135975ns10:FullAccounts2024-05-012025-04-3010135975ns10:OrdinaryShareClass22024-05-012025-04-3010135975ns10:OrdinaryShareClass32024-05-012025-04-3010135975ns10:Director22024-05-012025-04-3010135975ns10:RegisteredOffice2024-05-012025-04-3010135975ns5:CurrentFinancialInstruments2025-04-3010135975ns5:CurrentFinancialInstruments2024-04-3010135975ns5:ShareCapital2025-04-3010135975ns5:ShareCapital2024-04-3010135975ns5:RetainedEarningsAccumulatedLosses2025-04-3010135975ns5:RetainedEarningsAccumulatedLosses2024-04-3010135975ns5:FurnitureFittings2024-05-012025-04-3010135975ns5:MotorVehicles2024-05-012025-04-3010135975ns5:ComputerEquipment2024-05-012025-04-3010135975ns5:FurnitureFittings2024-04-3010135975ns5:MotorVehicles2024-04-3010135975ns5:ComputerEquipment2024-04-3010135975ns5:FurnitureFittings2025-04-3010135975ns5:MotorVehicles2025-04-3010135975ns5:ComputerEquipment2025-04-3010135975ns5:FurnitureFittings2024-04-3010135975ns5:MotorVehicles2024-04-3010135975ns5:ComputerEquipment2024-04-3010135975ns5:WithinOneYearns5:CurrentFinancialInstruments2025-04-3010135975ns5:WithinOneYearns5:CurrentFinancialInstruments2024-04-3010135975ns5:Non-currentFinancialInstrumentsns5:AfterOneYear2025-04-3010135975ns5:Non-currentFinancialInstrumentsns5:AfterOneYear2024-04-3010135975ns10:OrdinaryShareClass22025-04-3010135975ns10:OrdinaryShareClass32025-04-30
REGISTERED NUMBER: 10135975 (England and Wales)










UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 APRIL 2025

FOR

GRANVILLE-CHAPMAN ORTHOPAEDICS LIMITED

GRANVILLE-CHAPMAN ORTHOPAEDICS LIMITED (REGISTERED NUMBER: 10135975)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2025




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 4


GRANVILLE-CHAPMAN ORTHOPAEDICS LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30 APRIL 2025







DIRECTORS: Mr J Granville-Chapman
Mrs K E Granville-Chapman





REGISTERED OFFICE: Unit 2.02 High Weald House
Glovers End
Bexhill
East Sussex
TN39 5ES





REGISTERED NUMBER: 10135975 (England and Wales)





ACCOUNTANTS: Acuity Professional Partnership LLP
Unit 2.02 High Weald House
Glovers End
Bexhill
East Sussex
TN39 5ES

GRANVILLE-CHAPMAN ORTHOPAEDICS LIMITED (REGISTERED NUMBER: 10135975)

STATEMENT OF FINANCIAL POSITION
30 APRIL 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 25,742 32,178

CURRENT ASSETS
Debtors 5 262,500 269,181
Cash at bank 186,859 100,119
449,359 369,300
CREDITORS
Amounts falling due within one year 6 87,354 40,455
NET CURRENT ASSETS 362,005 328,845
TOTAL ASSETS LESS CURRENT
LIABILITIES

387,747

361,023

CAPITAL AND RESERVES
Called up share capital 7 100 100
Retained earnings 387,647 360,923
SHAREHOLDERS' FUNDS 387,747 361,023

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 April 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 April 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

GRANVILLE-CHAPMAN ORTHOPAEDICS LIMITED (REGISTERED NUMBER: 10135975)

STATEMENT OF FINANCIAL POSITION - continued
30 APRIL 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 1 December 2025 and were signed on its behalf by:





Mr J Granville-Chapman - Director


GRANVILLE-CHAPMAN ORTHOPAEDICS LIMITED (REGISTERED NUMBER: 10135975)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2025

1. STATUTORY INFORMATION

Granville-Chapman Orthopaedics Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

BASIS OF PREPARING THE FINANCIAL STATEMENTS
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

SIGNIFICANT JUDGEMENTS AND ESTIMATES
In preparing the financial statements, the directors are required to make estimates and judgments about the carrying amounts of assets and liabilities. The estimates and assumptions are reviewed on an ongoing basis and are based on historical experience and other factors that are considered by the directors to be relevant. Revision to accounting estimates are recognised in the period in which the estimate is revised.

TURNOVER
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

TANGIBLE FIXED ASSETS
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Office equipment - 15% on reducing balance
Motor vehicles - 25% on reducing balance
Computer equipment - 15% on reducing balance

GRANVILLE-CHAPMAN ORTHOPAEDICS LIMITED (REGISTERED NUMBER: 10135975)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 APRIL 2025

2. ACCOUNTING POLICIES - continued

FINANCIAL INSTRUMENTS
The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset , with the net amounts presented in the financial statements , when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payment is discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors greater than one year are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

TAXATION
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2024 - NIL).

GRANVILLE-CHAPMAN ORTHOPAEDICS LIMITED (REGISTERED NUMBER: 10135975)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 APRIL 2025

4. TANGIBLE FIXED ASSETS
Office Motor Computer
equipment vehicles equipment Totals
£    £    £    £   
COST
At 1 May 2024 10,433 51,890 890 63,213
Additions 1,084 - - 1,084
At 30 April 2025 11,517 51,890 890 64,297
DEPRECIATION
At 1 May 2024 4,163 26,581 291 31,035
Charge for year 1,103 6,327 90 7,520
At 30 April 2025 5,266 32,908 381 38,555
NET BOOK VALUE
At 30 April 2025 6,251 18,982 509 25,742
At 30 April 2024 6,270 25,309 599 32,178

5. DEBTORS
2025 2024
£    £   
Amounts falling due within one year:
Trade debtors 13,425 19,789
Other debtors 6,875 9,987
20,300 29,776

Amounts falling due after more than one year:
Other debtors 242,200 239,405

Aggregate amounts 262,500 269,181

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Taxation and social security 40,137 38,625
Other creditors 47,217 1,830
87,354 40,455

GRANVILLE-CHAPMAN ORTHOPAEDICS LIMITED (REGISTERED NUMBER: 10135975)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 APRIL 2025

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2025 2024
value: £    £   
50 Ordinary A Shares £1 50 50
50 Ordinary B Shares £1 50 50
100 100